Skip to content

Clinical trials

Completed Carcinoma, Transitional Cell trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Status: Completed Country / region: South Korea Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20081
20131
20151
20163
20173
20183
20192
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center2
Bayer2
Bristol-Myers Squibb2
Hoffmann-La Roche2
Pfizer2
Astellas Pharma Inc1
Basilea Pharmaceutica1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell18
Urinary Bladder Neoplasms10
Carcinoma, Non-Small-Cell Lung4
Ureteral Neoplasms3
Breast Neoplasms2
Melanoma2
Squamous Cell Carcinoma of Head and Neck2
Urethral Neoplasms2
Urologic Neoplasms2
Acrocephalosyndactylia1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.